Physician profile
Alexandra Lev
NPI 1568817054
$1,714.45
in general payments reported to CMS, 2019-2025
21 companies · $97.55 in 2025
The $97.55 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $627 · 2023: $365 · 2024: $218 · 2025: $97.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $668.26 | 2021-2023 | Watchman Access System, Watchman |
| E.R. Squibb & Sons, L.L.C. | $334.17 | 2021-2022 | |
| Cvrx, INC. | $151.13 | 2022-2025 | Barostim Neo System |
| Abiomed | $78.54 | 2023-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $62.21 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $48.78 | 2022-2023 | Xarelto |
| Pfizer INC. | $42.09 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $40.29 | 2021-2024 | Farxiga |
| Abbott Laboratories | $39.21 | 2023 | Amplatzer Amulet, Confirm Rx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.02 | 2021-2022 | |
| Medtronic, INC. | $35.37 | 2022-2023 | Micra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.18 | 2024-2025 | Jardiance |
| Atricure, INC. | $21.45 | 2024 | |
| Philips North America LLC | $18.64 | 2025 | Mcot |
| Kowa Pharmaceuticals America, INC. | $16.38 | 2024 | Livalo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.96 | 2023 | Verquvo |
| Amgen INC. | $14.61 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $14.29 | 2023 | Arcalyst |
| Esperion Therapeutics, INC. | $14.17 | 2021 | |
| Amarin Pharma, INC. | $13.50 | 2021 | |
| Azurity Pharmaceuticals, INC. | $13.20 | 2024 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Lev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.